Plasma EGF levels predict cognitive decline in Parkinson's Disease

OBJECTIVE: Most people with Parkinson's disease (PD) eventually develop cognitive impairment (CI). However, neither the timing of onset nor the severity of cognitive symptoms can be accurately predicted. We sought plasma-based biomarkers for CI in PD. METHODS: A discovery cohort of 70 PD patien...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Chen-Plotkin, Alice S., Hu, William T., Siderowf, Andrew, Weintraub, Daniel, Gross, Rachel Goldmann, Hurtig, Howard I., Xie, Sharon X., Arnold, Steven E., Grossman, Murray, Clark, Christopher M., Shaw, Leslie M., McCluskey, Leo, Elman, Lauren, Van Deerlin, Vivianna M., Lee, Virginia M.-Y., Soares, Holly, Trojanowski, John Q.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3155276/
https://ncbi.nlm.nih.gov/pubmed/21520231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.22271
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak